Aesthetic Medicine

LATEST NEWS

Avoiding Tattooing Risks

By

Brandon May

Dermatologists play a key role in detecting patients at risk for complications from tattooing.

Upneeq Approved for Acquired Blepharoptosis

By

Brian Park, PharmD

The FDA has approved Upneeq™ (oxymetazoline hydrochloride ophthalmic solution; Osmotica) for the treatment of acquired blepharoptosis in adults.

FDA Approves Qwo to Treat Moderate to Severe Cellulite

By

Brian Park, PharmD

Results from both studies showed treatment with Qwo was associated with greater reductions in cellulite severity compared with placebo as measured by CR-PCSS and PR-PCSS scales at day 71.

Attitude Toward Plastic Surgery Remains Positive During COVID-19

Americans have a positive attitude toward plastic surgery in the COVID-19 period, and recommendations have been issued for resuming elective procedures.

Restylane Kysse Approved for Lip Augmentation, Correction of Upper Perioral Rhytids

By

Brian Park, PharmD

The FDA has approved Restylane® Kysse (Galderma) for lip augmentation and the correction of upper perioral rhytids in adults aged >21 years.

Topical Cream with Tranexamic Acid Offers Noticeable Improvement in Facial Melasma

By

Brandon May

A cream with Tranexamic acid proves far more active than cream without Tranexamic in the treatment of inflammatory hypervascular and telangiectatic melasma.

Green Tea, Coffee Consumption May Alleviate, Prevent Skin Photoaging

By

Emily Pond

How much of an influence does the consumption of polyphenols have on the suppression of pigmented spots? A considerable influence, a study finds.

3-D Tattoo Device Aids With Nipple Reconstruction

A new device allows plastic surgeons to perform three-dimensional nipple tattoos as part of breast reconstruction.

New Technique Improves Face-Lifts for Balding Men

A new method of face-lift surgery eliminates visible scars for bald men undergoing the procedure.

Tixel-Induced Rapamycin Delivery After Pulsed Dye Laser for Port Wine Stain

By

Virginia A. Schad, PharmD, RPh

The use of the drug delivery system combined with topical rapamycin improves the results of pulsed dye laser (PDL) treatment for port wine stains and can reduce the total number of necessary PDL sessions, with no remarkable adverse events.